Article
Detrimental Effects of Apolipoprotein E4: Potential Therapeutic Targets in Alzheimers Disease
1 Dec 2007
Abstract excerpt
As the major genetic risk factor for Alzheimer's disease, the apolipoprotein (apo) E4 isoform is a promising therapeutic target. ApoE4 likely contributes to Alzheimer's disease pathology by interacting with multiple factors through various pathways. Interactions with the amyloid beta peptide and the amyloid cascade, for example, may lead to cognitive decline and neurodegeneration. Alternatively, apoE4 might act...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
